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Structure of Human Tyrosinase Related Protein 1 Reveals a Binuclear
Zinc Active Site Important for Melanogenesis
Xuelei Lai, Harry J. Wichers, Montserrat Soler-Lopez,* and Bauke W. Dijkstra*
Abstract: Tyrosinase-related protein 1 (TYRP1) is one of three
tyrosinase-like glycoenzymes in human melanocytes that are
key to the production of melanin, the compound responsible
for the pigmentation of skin, eye, and hair. Difficulties with
producing these enzymes in pure form have hampered the
understanding of their activity and the effect of mutations that
cause albinism and pigmentation disorders. Herein we show
that the typical tyrosinase-like subdomain of TYRP1 contains
two zinc ions in the active site instead of copper ions as found
in tyrosinases, which explains why TYRP1 does not exhibit
tyrosinase redox activity. In addition, the structures reveal for
the first time that the Cys-rich subdomain, which is unique to
vertebrate melanogenic proteins, has an epidermal growth
factor-like fold and is tightly associated with the tyrosinase
subdomain. Our structures suggest that most albinism-related
mutations of TYRP1 affect its stability or activity.
In humans, three enzymes are involved in the biosynthesis of
melanin (Figure S1 in the Supporting Information), the
primary determinant of the color of the skin, hair and iris of
the eye.[1] Tyrosinase (TYR) is the critical and rate-limiting
enzyme; it catalyzes the hydroxylation and subsequent
oxidation of tyrosine. Tyrosinase-related protein 2 (TYRP2)
is a tautomerase,[2] and tyrosinase-related protein 1 (TYRP1)
has been suggested to catalyze the oxidation of 5,6-dihydrox-
yindole-2-carboxylic acid (DHICA) in mice,[3] although this
activity has been challenged in humans.[4] All three enzymes
are metal-containing glycoproteins localized in melanosomes
where melanin synthesis takes place. They share approxi-
mately 40% amino acid sequence identity and contain four
conserved regions: an N-terminal signal peptide, an intra-
melanosomal domain, a single transmembrane a-helix, and
a small, flexible C-terminal cytoplasmic domain (Figure 1A).
The intramelanosomal domain contains a Cys-rich subdo-
main, unique to mammalian tyrosinases, and a tyrosinase-like
subdomain with a binuclear metal-ion-binding sequence
motif. Mutations in the TYR or TYRP1 genes result in
oculocutaneous albinism (OCA), a group of autosomal
recessive disorders characterized by reduced production of
melanin in skin, hair, and eyes, with OCA3 resulting from
TYRP1 mutations. In addition, TYR and TYRP1 variants are
significantly associated with risk of melanoma,[5] a malignant
tumor of melanocytes that, because of its aggressive nature,
causes the majority of deaths related to skin cancer.[6]
Inhibition of melanogenesis may be an efficient therapeutic
strategy, as evidenced by phase 1 clinical trials with a recombi-
nant human monoclonal antibody against TYRP1.[7]
Although we recently succeeded in the recombinant
production of intramelanosomal human TYR,[8] its crystal-
lization was not suitable for structure determination. Herein
we report the crystal structure of intramelanosomal human
TYRP1 and in complex with tyrosinase substrates and
inhibitors, which reveal for the first time the structure of
a mammalian tyrosinase family member. We show that the
active site contains two zinc ions, rather than copper ions as in
tyrosinases, which makes it unlikely that human TYRP1 is
a redox enzyme, as had been assumed for the last three
decades.
The 2.35c resolution crystal structure of intramelanoso-
mal TYRP1 (Figure 1B, Table S1) reveals a compact globular
shape, with tight interactions between the Cys-rich and
tyrosinase subdomains. Furthermore, all six Asn N-glycosy-
lation motifs bear glycans (96, 104, 181, 304, 350, and 385)
(Figure 1B and Figure S2). The tyrosinase-like subdomain
(residues 127–477) has the typical tyrosinase fold, consisting
of a four-helix bundle (a3, a4, a8, and a9) connected by long
loops. It is most similar to the bacterial Bacillus megaterium
tyrosinase (BmTYR, PDB entry 3NM8),[9] with 32%
sequence identity and an rmsd of 1.6 c for 263 aligned
amino acids. The most conspicuous differences are three long
insertions that cluster together at one side of the tyrosinase-
like subdomain (Figure 2; residues 155–182, 199–204, and
291–300). These loops extend away from the entrance to the
active site, and interact with the Cys-rich subdomain. Two
disulfide bonds (C258–C261 and C290–C303) stabilize the
tyrosinase subdomain (disulfide bonds 6 and 7 in Figure S2).
The core of the Cys-rich subdomain (residues 25–126) has
an epidermal growth factor (EGF)-like fold (SCOP family
g.3.11.1) similar to the structure of the human epidermal
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growth factor (Figure S3), formed by two pairs of
short antiparallel b-strands (b1/b2 (residues 62–
66/98–102) and b4/b5 (116–118/124–126; Fig-
ure 1B) from which long loops emerge. They are
stabilized by disulfide bonds that follow the [C1–
C3, C2–C4, C5–C6] signature pattern of EGF-like
structures,[10] corresponding to cysteine residues
42–65, 56–99, 101–110. The subdomain associates
with the tyrosinase-like subdomain via its N-
terminus and the long 67–97 loop extending
from the core. The subdomain is located far from
the active site, at the opposite side of the molecule
(Figure 1B), making a direct effect on the activity
of TYRP1 unlikely. Although the Cys-rich sub-
domain has been suggested to be involved in
oligomerization,[11] we did not find evidence for
this, since purified intramelanosomal domains of
both TYRP1 and TYR elute as monomers on size-
exclusion chromatography (Figure S4A), and co-
elution of TYRP1 and TYR did neither produce
a heterodimer (Figure S4B).
TYRP1 has a binuclear metal-binding site that
resembles the classical type-3 binuclear copper-
binding site of hemocyanins and tyrosinases
(Figure 3), but the nature of the bound metal
ions has been unclear.[12] Using X-ray fluores-
cence, we found that TYRP1 crystals contained zinc, while
TYR crystals contained copper (Figure S5). The presence of
zinc in TYRP1 was further confirmed by X-ray anomalous
dispersion data collected at the zinc absorption edge, which
showed that the TYRP1 zinc ions occupy the positions of
copper ions in tyrosinases (Figure S6 and Table S1). Both zinc
ions in the active site are bound with a nearly planar trigonal
geometry, slightly out of the plane defined by the Ne2 atoms
of their ligands. The distance between the ZnA and ZnB ions
(Figure 3) is 3.5: 0.1 c. A bridging water molecule or
Figure 1. A) TYRP1 contains 4 conserved regions: the signal peptide (yellow, residues
1–24), the intramelanosomal (or luminal) domain (25–477, subdivided into the Cys-
rich (green, 25–126) and the tyrosinase-like (blue, 127–477) subdomains), the trans-
membrane a-helix (gray, 478–501), and the cytoplasmic domain (orange, 502–537).
B) Overall structure of the intramelanosomal domain, same coloring as in (A). The
six Asn sites with N-linked sugars (96, 104, 181, 304, 350, and 385) are shown as
sticks and the disulfide bonds are shown in orange. The two metal ions (A and B)
are shown as pink spheres.
Figure 2. Superposition of the TYRP1 and Bacillus megaterium TYR
crystal structures. BmTYR is represented as a gray structure and light
gray surface (PDB 3NM8).[9] The tyrosinase subdomain of TYRP1 is
shown in blue and the Cys-rich subdomain in light green. Loops with
different lengths between TYRP1 and BmTYR are indicated. Disulfide
bonds are shown in orange and the two metal ions (A and B) in pink.
The disulfide residues stabilizing the TYRP1 tyrosinase subdomain are
indicated as orange sticks.
Figure 3. Metal-ion binding in the TYRP1 active site. A) Close-up of the
TYRP1 active site. Zn ions are shown as pink spheres with the bridging
water molecule in red (wzn). Metal coordination distances are labeled.
B) Superposition of TYRP1 and BmTYR active sites. The Cu ions
present in BmTYR are shown in orange, and the bridging water
molecule (wcu) in red. Metal-coordination distances are displayed in
dark gray and labeled. The location of metal B is better conserved than
metal A, in agreement with previous observations[14] (see Figure 5).
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hydroxide ion can be modeled with a distance of 2.1: 0.1 c
to the two zinc ions (Figure 3A and Figure S7A). Although
we carried out repeated productions of TYRP1 and TYR
samples under identical cell culture conditions and in the
absence of external sources of zinc or copper ions in the
media, the two proteins consistently contain different ions,
unambiguously proving that TYR is a copper-binding enzyme
while TYRP1 is a zinc-binding enzyme.
Generally, it has been assumed that TYRP1 is a DHICA
oxidase.[13] Yet, human TYRP1 was found to be devoid of
DHICA activity,[4] and also in our studies the intramelano-
somal domain of TYRP1 did not display any DHICA activity
nor tyrosine hydroxylase or l-DOPA oxidase activity
(Figure 4). The nature of the metal ions in the active site is
partly responsible for these differences in activity, since
exchanging the Zn2+/Cu2+ cofactors of TYRP1/TYR for Cu2+/
Zn2+ conferred TYR-level DHICA oxidase activity to
TYRP1, but no significant l-DOPA oxidase and tyrosine
hydroxylase activities. Only a prolonged (up to 160 min) on-
plate tyrosinase activity assay with TYRP1-Cu did show some
low tyrosinase activity (Figure 4D). In contrast, TYR-Zn had
almost no activity, with the residual activity likely resulting
from incomplete removal of the copper ions. Amino acid
substitutions in the active site affect the activity profile only to
a minor extent. A triple mutant, which had the three non-
identical residues replaced by the corresponding ones of TYR
(Y362F/R374S/T391V; TYRP1-3M), had similar activities as
native TYRP1, both in the Zn- and Cu-substituted forms.
Thus, our results suggest that it is unlikely that TYRP1 is
a redox enzyme.
TYRP1 binds typical tyrosinase substrates and inhibitors
(Figure 5, Table S1). Importantly, l-tyrosine and the l-DOPA
analogue l-mimosine do not directly interact with the zinc
ions, but their aromatic hydroxy and keto-groups are hydro-
gen-bonded to the water molecule bridging the two zinc ions
(Figure S7B). Additional interactions include offset aromatic
stacking interactions with His381, and hydrogen bonding
interactions of their carboxylate group with Arg374 and
Ser394 (Figure 5A,B). The electron density of l- mimosine is
better defined than that of l-tyrosine, suggesting that the
interactions of the e-hydroxy group increase the binding
affinity of mimosine. In contrast, the metal chelator tropolone
does have direct interactions with the ZnA ion (Figure 5C).
Interestingly, ZnA has shifted by 1.5 c towards tropolone
compared to native TYRP1, indicating that the metal ion site
is somewhat flexible. The skin-whitening agent kojic acid
binds with its ring hydroxy and keto groups at approximately
3 c from the zinc ions, which is too far for good coordination
(Figure 5D). Interestingly, the amino acid differences
between the active sites of TYRP1 and TYR do not affect
the binding modes of these compounds, as shown by crystal
structures of the TYRP1-3Mmutant (see above) with/without
bound l-mimosine, tropolone and kojic acid (Fig-
ure S8, Table S1). Despite removal of hydrogen-
bonding interactions by the mutations, the com-
pounds bind in a similar conformation as in native
TYRP1. Apparently, the stacking interaction with
His381 and the hydrogen bonds of aromatic keto-
and hydroxy groups are sufficient for binding. This
finding implies that recognition of the substrateQs
carboxylate group is not essential and that, in
addition to DHICA, TYRP1 may also be active on
5,6-dihydroxyindole (DHI) (Figure S1).
Fifteen OCA3-related mutations in the
TYRP1 gene have so far been found, including 8
point mutations (C30R, R93C, H215Y, T253M,
C290Y, R356Q, M452V, and P513R; Figure S9).[15]
Most of these residues contribute to the stability.
The C30–C41 disulfide bond attaches helix a1 to
the core of the Cys-rich subdomain, the C290–
C303 disulfide bond stabilizes the 290–303 loop,
and R356 is part of an extensive buried hydrogen-
bonding network. H215 is a ZnA ligand, and
replacement by Tyr may reduce the enzymeQs zinc-
binding affinity and activity. T253M and M452V
are missense mutations found in Caucasian
patients that are yet to be confirmed as patholog-
ical mutations.[16]
T253 is located on a surface loop, far away
from the active site, and the introduction of a large
apolar methionine at this position may lead to
local unfolding and/or aggregation. M452 is
located in the interface between the Cys-rich and
tyrosinase-like subdomains. Replacement by Val
may reduce part of its hydrophobic interactions,
Figure 4. A)–C) Activity assays of TYR,[8] TYRP1, and their corresponding apo-
proteins recharged with Zn or Cu ions. TYRP1-3M is the triple Y362F/R374S/T391V
mutant. For details see Table S2. D) Colorimetric activity assay. Enzymes added are
indicated on the right. The pink pigment is the tyrosinase activity product
dopaquinone in complex with MBTH, which appears after ca. 1 min for TYR, ca.
20 min for TYRP1-3M-Cu, and ca. 40 min for TYRP1-Cu, and accumulates over time.
Well 1 (W1) is a blank control. W2*, W4*, and W6* contain tyrosinase inhibitors as
negative controls. W3 and W5 show no pigment, indicating that TYRP1 and TYRP1-
3M have no tyrosinase activity. W6 is darker than W4 at the same time point,
indicating that TYRP1-3M-Cu presents higher tyrosinase activity than TYRP1-Cu.
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which may have a (probably minor) effect on the stability of
the enzyme. The R93C substitution causes blond hair in
normally black-haired Melanesian individuals.[17] R93 is near
a cluster of four disulfide bonds in the Cys-rich subdomain
(Figure S9), and replacement by a cysteine could interfere
with correct disulfide bond formation or even correct folding.
Finally, the P513R mutation is in the cytosolic tail domain,
which is critical for targeting melanogenic proteins to the
melanosomal membrane.[18] The P513R replacement may
thus interfere with translocation of TYRP1 to the melanoso-
mal membrane.
In summary, the crystal structure of intramelanosomal
human tyrosinase-related protein 1 (TYRP1) has revealed for
the first time the structure of a mammalian tyrosinase family
member. We provide compelling evidence for the presence of
two zinc ions in the active site, which makes it unlikely that
human TYRP1 is a redox enzyme, in contrast to what has
been assumed for the last three decades. Which reaction
TYRP1 does catalyze is unclear at this moment, although the
effect of mutations in the TYRP1 gene suggest the utmost
importance of TYRP1 for the biosynthesis of melanin.
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Figure 5. Binding of tyrosinase substrates and inhibitors. l-tyrosine (A)
and mimosine (B) bind with their carboxylate groups to R374. Tropolo-
ne (C) and kojic acid (D) bind in the same position. Each compound
is shown with its 2Fo@Fc electron density map (gray wire) contoured at
0.9s. Zinc ions are shown as pink spheres and water molecules as red
spheres. Contacts of the compounds with TYRP1 residues and the Zn
ions are shown as dashed lines.
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